Alligator Bioscience and Aptevo Therapeutics Report Positive Interim Data in Phase 1 Study of ALG.APV-527 for Solid Tumor Cancers.
Therapeutics Company Announces Positive Data…
Alligator Bioscience and Aptevo Therapeutics Report Positive Interim Data in Phase 1 Study of ALG.APV-527 for Solid Tumor Cancers.